Publicacións nas que colabora con Miguel Santín Cerezales (11)

2024

  1. Editorial: Addressing tuberculosis infection: an essential step in the fight against tuberculosis

    Frontiers in Medicine

2023

  1. Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study

    PLoS ONE, Vol. 18, Núm. 8 August

2022

  1. Comparison of three short-course rifamycinbased regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial)

    PLoS ONE, Vol. 17, Núm. 10 October

2021

  1. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study

    Microbiology Spectrum, Vol. 9, Núm. 3

2018

  1. QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial

    Clinical Infectious Diseases, Vol. 66, Núm. 3, pp. 396-403

2016

  1. Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study

    Clinical Microbiology and Infection, Vol. 22, Núm. 12, pp. 1007.e1-1007.e5

  2. Executive Summary of the Guidelines for the Use of interferon-gamma Release Assays in the Diagnosis of Tuberculosis Infection

    Archivos de Bronconeumologia, Vol. 52, Núm. 9, pp. 477-481

  3. Executive summary of the guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 5, pp. 304-308

  4. Guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 5, pp. 303.e1-303.e13

2011

  1. Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-γ release assay in patients considered for anti-tumor necrosis factor-α therapy

    Diagnostic Microbiology and Infectious Disease, Vol. 71, Núm. 1, pp. 57-65

2010

  1. Treatment completion in latent tuberculosis infection at specialist tuberculosis units in Spain

    International Journal of Tuberculosis and Lung Disease, Vol. 14, Núm. 6, pp. 701-707